Catalyst Pharmaceuticals Stock Price History
| CPRX Stock | USD 24.23 1.07 4.62% |
Below is the normalized historical share price chart for Catalyst Pharmaceuticals extending back to November 08, 2006. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Catalyst Pharmaceuticals stands at 24.23, as last reported on the 23rd of March, with the highest price reaching 24.48 and the lowest price hitting 23.17 during the day.
If you're considering investing in Catalyst Stock, it is important to understand the factors that can impact its price. Catalyst Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Catalyst Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0739, which signifies that the company had a 0.0739 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Catalyst Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of Catalyst Pharmaceuticals' Downside Deviation of 2.33, risk adjusted performance of 0.0741, and Mean Deviation of 2.08 to double-check if our risk estimates are consistent with your expectations.
At this time, Catalyst Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 131.2 M in 2025, whereas Common Stock Total Equity is likely to drop slightly above 66.6 K in 2025. . At this time, Catalyst Pharmaceuticals' Price Earnings Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.15 in 2025, whereas Price To Sales Ratio is likely to drop 4.78 in 2025. Catalyst Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of November 2006 | 200 Day MA 20.1988 | 50 Day MA 22.3642 | Beta 0.836 |
Catalyst |
Sharpe Ratio = 0.0739
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CPRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.2 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Catalyst Pharmaceuticals is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Catalyst Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 4.0442 | Enterprise Value Ebitda 10.4267 | Price Sales 5.9844 | Shares Float 113.8 M | Wall Street Target Price 33.3333 |
Catalyst Pharmaceuticals Stock Price History Chart
There are several ways to analyze Catalyst Stock price data. The simplest method is using a basic Catalyst candlestick price chart, which shows Catalyst Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 21, 2025 | 24.23 |
| Lowest Price | January 7, 2025 | 19.53 |
Catalyst Pharmaceuticals March 23, 2025 Stock Price Synopsis
Various analyses of Catalyst Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Catalyst Stock. It can be used to describe the percentage change in the price of Catalyst Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Catalyst Stock.| Catalyst Pharmaceuticals Price Rate Of Daily Change | 1.05 | |
| Catalyst Pharmaceuticals Price Daily Balance Of Power | 0.82 | |
| Catalyst Pharmaceuticals Price Action Indicator | 0.94 |
Catalyst Pharmaceuticals March 23, 2025 Stock Price Analysis
Catalyst Stock Price History Data
The price series of Catalyst Pharmaceuticals for the period between Mon, Dec 23, 2024 and Sun, Mar 23, 2025 has a statistical range of 4.7 with a coefficient of variation of 4.15. The prices are distributed with arithmetic mean of 22.1. The median price for the last 90 days is 22.1.| Open | High | Low | Close | Volume | ||
03/23/2025 | 23.25 | 24.48 | 23.17 | 24.23 | ||
| 03/21/2025 | 23.25 | 24.48 | 23.17 | 24.23 | 4,923,860 | |
| 03/20/2025 | 22.28 | 23.17 | 22.21 | 23.16 | 1,145,528 | |
| 03/19/2025 | 22.03 | 22.74 | 21.94 | 22.60 | 1,003,873 | |
| 03/18/2025 | 21.78 | 22.16 | 21.53 | 22.08 | 1,363,249 | |
| 03/17/2025 | 21.10 | 21.84 | 20.99 | 21.81 | 1,202,378 | |
| 03/14/2025 | 20.93 | 21.19 | 20.84 | 21.02 | 1,110,520 | |
| 03/13/2025 | 21.07 | 21.25 | 20.68 | 20.87 | 829,628 | |
| 03/12/2025 | 21.08 | 21.42 | 20.89 | 21.20 | 1,277,009 | |
| 03/11/2025 | 20.68 | 21.16 | 20.23 | 20.96 | 1,897,551 | |
| 03/10/2025 | 21.52 | 21.67 | 20.62 | 20.67 | 1,245,805 | |
| 03/07/2025 | 21.66 | 22.24 | 21.40 | 21.96 | 1,021,517 | |
| 03/06/2025 | 21.64 | 21.96 | 21.45 | 21.67 | 1,063,225 | |
| 03/05/2025 | 22.11 | 22.47 | 21.89 | 21.89 | 993,237 | |
| 03/04/2025 | 22.08 | 22.54 | 22.00 | 22.10 | 989,299 | |
| 03/03/2025 | 22.89 | 23.39 | 22.27 | 22.32 | 1,526,642 | |
| 02/28/2025 | 21.93 | 22.90 | 21.69 | 22.89 | 1,482,401 | |
| 02/27/2025 | 22.32 | 23.55 | 21.42 | 21.66 | 2,672,596 | |
| 02/26/2025 | 20.59 | 20.96 | 20.50 | 20.58 | 1,286,454 | |
| 02/25/2025 | 21.28 | 21.51 | 20.46 | 20.80 | 1,522,121 | |
| 02/24/2025 | 21.63 | 21.89 | 21.24 | 21.25 | 888,930 | |
| 02/21/2025 | 22.26 | 22.27 | 21.35 | 21.62 | 918,558 | |
| 02/20/2025 | 22.39 | 22.55 | 21.91 | 22.05 | 823,855 | |
| 02/19/2025 | 22.65 | 22.80 | 22.46 | 22.53 | 784,936 | |
| 02/18/2025 | 23.32 | 23.59 | 22.67 | 22.93 | 1,089,895 | |
| 02/14/2025 | 23.26 | 23.35 | 22.85 | 23.27 | 954,576 | |
| 02/13/2025 | 22.78 | 23.26 | 22.52 | 23.26 | 656,640 | |
| 02/12/2025 | 22.40 | 23.03 | 22.40 | 22.70 | 808,171 | |
| 02/11/2025 | 22.56 | 22.74 | 22.18 | 22.58 | 719,976 | |
| 02/10/2025 | 23.02 | 23.20 | 22.73 | 22.76 | 765,450 | |
| 02/07/2025 | 23.08 | 23.22 | 22.82 | 22.90 | 592,359 | |
| 02/06/2025 | 23.30 | 23.64 | 23.00 | 23.06 | 1,241,083 | |
| 02/05/2025 | 23.17 | 23.74 | 23.07 | 23.40 | 957,739 | |
| 02/04/2025 | 22.85 | 23.20 | 22.57 | 23.09 | 850,541 | |
| 02/03/2025 | 22.29 | 23.40 | 21.69 | 22.62 | 1,223,956 | |
| 01/31/2025 | 23.25 | 23.50 | 22.44 | 22.56 | 1,052,243 | |
| 01/30/2025 | 24.16 | 24.64 | 23.16 | 23.19 | 996,219 | |
| 01/29/2025 | 22.84 | 24.24 | 22.84 | 23.96 | 1,132,329 | |
| 01/28/2025 | 22.69 | 23.10 | 22.55 | 22.84 | 624,200 | |
| 01/27/2025 | 22.19 | 23.14 | 22.07 | 22.70 | 1,193,548 | |
| 01/24/2025 | 22.50 | 22.91 | 22.13 | 22.55 | 653,567 | |
| 01/23/2025 | 22.64 | 22.70 | 21.97 | 22.51 | 1,053,754 | |
| 01/22/2025 | 22.92 | 23.13 | 22.65 | 22.87 | 753,312 | |
| 01/21/2025 | 22.99 | 23.15 | 22.32 | 22.92 | 1,170,472 | |
| 01/17/2025 | 22.85 | 23.01 | 22.46 | 22.78 | 4,930,320 | |
| 01/16/2025 | 23.07 | 23.26 | 22.15 | 22.66 | 1,592,052 | |
| 01/15/2025 | 22.51 | 23.13 | 22.11 | 23.06 | 1,496,364 | |
| 01/14/2025 | 22.29 | 22.89 | 21.84 | 22.19 | 1,359,858 | |
| 01/13/2025 | 21.80 | 22.26 | 21.23 | 22.21 | 1,614,413 | |
| 01/10/2025 | 22.85 | 22.98 | 21.34 | 21.92 | 2,510,325 | |
| 01/08/2025 | 19.57 | 24.00 | 19.15 | 22.80 | 3,095,377 | |
| 01/07/2025 | 20.18 | 20.22 | 19.43 | 19.53 | 1,754,293 | |
| 01/06/2025 | 21.25 | 21.30 | 20.03 | 20.19 | 1,216,085 | |
| 01/03/2025 | 21.55 | 21.59 | 21.25 | 21.31 | 564,366 | |
| 01/02/2025 | 21.08 | 21.74 | 21.01 | 21.52 | 862,577 | |
| 12/31/2024 | 21.14 | 21.30 | 20.82 | 20.87 | 595,485 | |
| 12/30/2024 | 21.36 | 21.36 | 20.93 | 21.07 | 433,072 | |
| 12/27/2024 | 21.89 | 21.94 | 21.27 | 21.47 | 994,634 | |
| 12/26/2024 | 21.48 | 21.93 | 21.45 | 21.91 | 565,475 | |
| 12/24/2024 | 21.54 | 21.64 | 21.35 | 21.62 | 247,349 | |
| 12/23/2024 | 21.21 | 21.63 | 21.21 | 21.60 | 595,252 |
About Catalyst Pharmaceuticals Stock history
Catalyst Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Catalyst is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Catalyst Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Catalyst Pharmaceuticals stock prices may prove useful in developing a viable investing in Catalyst Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 124.9 M | 131.2 M | |
| Net Income Applicable To Common Shares | 95.5 M | 100.3 M |
Catalyst Pharmaceuticals Quarterly Net Working Capital |
|
Catalyst Pharmaceuticals Stock Technical Analysis
Catalyst Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Catalyst Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Catalyst Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Catalyst Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Catalyst to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0741 | |||
| Jensen Alpha | 0.3001 | |||
| Total Risk Alpha | 0.4631 | |||
| Sortino Ratio | 0.1256 | |||
| Treynor Ratio | 0.2045 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Catalyst Stock Analysis
When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.